The purpose of the study is to determine the recommended dose of durvalumab and tremelimumab (immunotherapy drugs) in pediatric patients...
Bowel preparation for pediatric colonoscopy.
Severe sepsis and septic shock remain of particular gravity in children with a current mortality of about 20 % ,...
Background: Some patients with unusual genetic conditions are referred to the National Institutes of Health (NIH). They may not be...
This is an event driven Phase 3, prospective, randomized, open-label, blinded endpoint evaluation (PROBE) parallel group study in subjects with...
The study has been designed with three components. Part A is an open label PK study followed by a randomized...
The aim of this study is to evaluate the safety and efficacy of 67Cu-SARTATE in pediatric patients with high-risk neuroblastoma.
The study is a Phase 2, multicounty, multicenter, non-confirmatory, investigator- and subject masked, randomized, placebo-controlled study to evaluate the safety,...
This study will evaluate the efficacy and safety of erenumab in migraine prevention in children (6 to <12 years) and...
Multicenter, open-label, non-comparative study to evaluate the pharmacokinetics, pharmacodynamics, and tolerability of osilodrostat in children and adolescent patients with ...
This is a Phase 3 Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS)
Patient are being asked to provide respiratory and blood samples for a clinical research study because the patients have a...
The purpose of this study is to evaluate long-term safety and tolerability data in eligible CLCZ696B2319 (PANORAMA-HF) patients receiving open-label...
The main aim of the study is to check effectiveness of rVWF (vonicog alfa) prophylaxis based on the annualized bleeding...
This study is conducted in China only. The purpose is to demonstrate the efficacy and safety of once weekly dosing...
The purpose of this study is to provide continued access to rilpivirine (RPV) for participants who were treated with RPV...
This study will evaluate the safety, tolerability, and descriptive efficacy of BIIB017 in pediatric participants with relapsing-remitting multiple sclerosis (RRMS)...
The primary purpose of this study is to evaluate the safety and tolerability of ASP0367. This study will also evaluate...
The primary objective of the study is to demonstrate the non-inferiority of the antibody responses to meningococcal serogroups A, C,...
Primary objective is to demonstrate the non-inferiority of the antibody response against meningococcal serogroups A, C, Y, and W following...
The purpose of this study is to monitor the long-term safety of ustekinumab in pediatric participants (6 years to 17...
The purpose of this study is to assess the efficacy of a single (first) dose of 3 fixed doses of...
This study is a Phase 3, randomized, double-blind, placebo-controlled study of voxelotor in pediatric participants, aged ≥ 2 to <...
English (USA)